SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Fyodor Dostoevsky Synthetic CCD

PatientFyodor Dostoevsky
Date of birth1982-11-11
IdentifiersMRN HR-NI018-SYN; SSN (made up) 000-18-3907
Document date2026-11-01
AuthorAgnes Lindahl, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing care after recurrent seizures: seizure history, baseline tests, EEG and MRI orders, seizure safety, and gambling-disorder assessment with a safety assessment. Concerns: He wants the seizures to stop interrupting his writing and his deadlines; He wants to stop losing money at roulette and to pay off his debts. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Lamotrigine 25 mg tablets, slow titration: 25 mg once daily for weeks 1 and 2, 50 mg once daily for weeks 3 and 4, 50 mg twice daily for week 5, and 75 mg twice daily for week 625 mg once daily, increased every two weeks and then weekly as written, to 75 mg twice daily in week 6Oral route2026-03-03 to 2026-04-13completedS
Lamotrigine 100 mg tablet, one tablet twice daily100 mg twice daily (200 mg a day), 30-day supply at a timeOral route2026-04-14activeS

Procedures

ProcedureDatesStatusEvidence
Routine EEG with photic stimulation and hyperventilation: normal background, no epileptiform discharges2026-02-17 to 2026-02-17completedS
MRI of the brain, epilepsy protocol: normal, with no hippocampal sclerosis, cortical malformation, or other lesion2026-02-20 to 2026-02-20completedS
Sleep-deprived EEG: normal, with no epileptiform discharges in wakefulness or sleep2026-03-24 to 2026-03-24completedS
Advance care planning conversation, about 20 minutes2026-10-20 to 2026-10-20completedS

Immunizations

DateVaccineStatusEvidence
2021-05-12Tetanus, diphtheria, and pertussis (Tdap) boostercompletedS
2026-10-20Influenza vaccine, 2026-2027 seasoncompletedS
2026-10-20Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1849Epilepsy since early adulthood, with recurrent seizures; the timing of onset and diagnosis differs between accountsR (CLM-0003)
1853Seizures worsened during four years of forced labor in the prison at OmskD (CLM-0004)
1863Sought expert advice on his epilepsy from neurologists abroadD (CLM-0002)
1863Compulsive roulette gambling with losses and pawned belongings, beginning on a tour of EuropeD (CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He wants the seizures to stop interrupting his writing and his deadlinesactiveS
He wants to stop losing money at roulette and to pay off his debtsactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.6 on 2026-02-03; Leukocytes [#/volume] in Blood by Automated count 6.8 on 2026-02-03; Platelets [#/volume] in Blood by Automated count 248 on 2026-02-03; Sodium [Moles/volume] in Serum or Plasma 137 on 2026-06-09; Potassium [Moles/volume] in Serum or Plasma 3.6 on 2026-06-09; Creatinine [Mass/volume] in Serum or Plasma 1.08 on 2026-06-09; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 98 on 2026-02-03; Glucose [Mass/volume] in Serum or Plasma 84 on 2026-06-09; Calcium [Mass/volume] in Serum or Plasma 9.5 on 2026-02-03; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-02-03; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 2026-02-03; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 32 on 2026-02-03; Hemoglobin A1c/Hemoglobin.total in Blood 5.3 on 2026-02-03; Cholesterol [Mass/volume] in Serum or Plasma 182 on 2026-02-03; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 2026-02-03; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 108 on 2026-02-03; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-02-03; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 on 2026-10-06; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 on 2026-10-06; Total score [AUDIT-C] 2 on 2026-10-20; lamoTRIgine [Mass/volume] in Serum or Plasma 5.9 on 2026-10-06; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-10-20 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Epilepsy of unknown type with recurrent generalized tonic-clonic seizures of unknown onset, untreated for many years; etiology unknownactiveconfirmed G40.909S — Synthetic modern coding of his documented epilepsy. The seizure type is left as unknown onset under the ILAE classification, because the retrospective classifications are disputed; no focal or generalized syndrome is coded.
Gambling disorder (roulette, in person and online), moderate, with debtsactiveconfirmed F63.0S — Synthetic modern coding of his documented compulsive roulette gambling.
Acute viral gastroenteritis with vomiting and two missed lamotrigine doses, without dehydration needing intravenous fluids; resolvedresolvedconfirmed A08.4S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach missed antiseizure doses during vomiting; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-03Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
2026-02-03Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-02-03Platelets [#/volume] in Blood by Automated count24810*3/uL150-400 10*3/uLNormalS
2026-02-03Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-02-03Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-02-03Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.74-1.35 mg/dLNormalS
2026-02-03Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M98mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-03Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
2026-02-03Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
2026-02-03Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-56 U/LNormalS
2026-02-03Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L10-40 U/LNormalS
2026-02-0325-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma32ng/mL30-100 ng/mLNormalS
2026-02-03Hemoglobin A1c/Hemoglobin.total in Blood5.3%<=5.6%NormalS
2026-02-03Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=200 mg/dLNormalS
2026-02-03Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
2026-02-03Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation108mg/dL<=129 mg/dLNormalS
2026-02-03Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-02-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-02-03Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S
2026-02-03Total score [AUDIT-C]2{score}S
2026-05-05lamoTRIgine [Mass/volume] in Serum or Plasma6.2ug/mL2.5-15 ug/mLNormalS
2026-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-07-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-10-06lamoTRIgine [Mass/volume] in Serum or Plasma5.9ug/mL2.5-15 ug/mLNormalS
2026-10-06Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-10-06Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]8{score}S
2026-06-09Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-06-09Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
2026-06-09Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.74-1.35 mg/dLNormalS
2026-06-09Glucose [Mass/volume] in Serum or Plasma84mg/dL70-99 mg/dLNormalS
2026-10-20Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-10-20Total score [AUDIT-C]2{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-02-03Body height170cmS
2026-02-03Body weight68kgS
2026-02-03Body mass index (BMI) [Ratio]23.5kg/m2S
2026-02-03Systolic blood pressure122mm[Hg]S
2026-02-03Diastolic blood pressure78mm[Hg]S
2026-02-03Heart rate74/minS
2026-02-03Respiratory rate14/minS
2026-02-03Body temperature36.7CelS
2026-02-03Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-03-03Body height170cmS
2026-03-03Body weight68.4kgS
2026-03-03Body mass index (BMI) [Ratio]23.7kg/m2S
2026-03-03Systolic blood pressure120mm[Hg]S
2026-03-03Diastolic blood pressure76mm[Hg]S
2026-03-03Heart rate72/minS
2026-03-03Respiratory rate14/minS
2026-03-03Body temperature36.6CelS
2026-03-03Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-05Body height170cmS
2026-05-05Body weight68.8kgS
2026-05-05Body mass index (BMI) [Ratio]23.8kg/m2S
2026-05-05Systolic blood pressure118mm[Hg]S
2026-05-05Diastolic blood pressure76mm[Hg]S
2026-05-05Heart rate70/minS
2026-05-05Respiratory rate14/minS
2026-05-05Body temperature36.7CelS
2026-05-05Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-07-07Body height170cmS
2026-07-07Body weight68.6kgS
2026-07-07Body mass index (BMI) [Ratio]23.7kg/m2S
2026-07-07Systolic blood pressure120mm[Hg]S
2026-07-07Diastolic blood pressure78mm[Hg]S
2026-07-07Heart rate70/minS
2026-07-07Respiratory rate14/minS
2026-07-07Body temperature36.6CelS
2026-07-07Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-06Body height170cmS
2026-10-06Body weight68kgS
2026-10-06Body mass index (BMI) [Ratio]23.5kg/m2S
2026-10-06Systolic blood pressure126mm[Hg]S
2026-10-06Diastolic blood pressure80mm[Hg]S
2026-10-06Heart rate78/minS
2026-10-06Respiratory rate14/minS
2026-10-06Body temperature36.7CelS
2026-10-06Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-09Body height170cmS
2026-06-09Body weight67.2kgS
2026-06-09Body mass index (BMI) [Ratio]23.3kg/m2S
2026-06-09Systolic blood pressure112mm[Hg]S
2026-06-09Diastolic blood pressure72mm[Hg]S
2026-06-09Heart rate96/minS
2026-06-09Respiratory rate16/minS
2026-06-09Body temperature37.6CelS
2026-06-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-20Body height170cmS
2026-10-20Body weight68.2kgS
2026-10-20Body mass index (BMI) [Ratio]23.6kg/m2S
2026-10-20Systolic blood pressure122mm[Hg]S
2026-10-20Diastolic blood pressure78mm[Hg]S
2026-10-20Heart rate72/minS
2026-10-20Respiratory rate14/minS
2026-10-20Body temperature36.6CelS
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-02-03Establishing care after recurrent seizures: seizure history, baseline tests, EEG and MRI orders, seizure safety, and gambling-disorder assessment with a safety assessmentfinishedS
2026-03-03Four-week follow-up with neurology consultation; EEG and MRI reviewed and lamotrigine startedfinishedS
2026-05-05Two-month review: lamotrigine at maintenance dose, rash and mood check, and gambling treatment progressfinishedS
2026-07-07Four-month review of seizure control, mood, and gambling recoveryfinishedS
2026-10-06Eight-month review after a breakthrough seizure and a gambling lapse while travelingfinishedS
2026-06-09Same-day sick visit for vomiting and diarrhea with missed lamotrigine dosesfinishedS
2026-10-20Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Neurology consultation for seizure classification, EEG and MRI review, and the choice of antiseizure medicinecompletedGL-AAN-FIRSTSZ-2015, GL-ILAE-SZ-2017, GL-ILAE-EPI-2017S
Antiseizure medicine: lamotrigine with slow titration, rash teaching, 30-day supplies, a pill organizer and phone alarms, a seizure diary, and levels only when they would change carecompletedGL-AAN-NEWASM-2018, GL-SANAD2-2021S
Seizure safety at every visit: triggers (sleep loss, alcohol, overwork), showers rather than baths, no swimming or heights alone, no driving until seizure-free and cleared by his neurologist, a written seizure action plan for friends, and a SUDEP discussioncompletedGL-AAN-SUDEP-2017, GL-AAN-FIRSTSZ-2015S
Gambling-disorder treatment: cognitive behavioral therapy with a gambling-disorder therapist, self-exclusion, a bank gambling block, Gamblers Anonymous, and free debt counselingcompletedGL-GAMB-COCHRANE-2012, GL-GAMB-NRDP-2019S
Mood and safety: PHQ-9 at intake and every two to four months, GAD-7 at intake and with any change, and a suicide-risk review with the 988 Suicide & Crisis Lifeline at every visitcompletedGL-CMID-2026, GL-ILAE-DEP-2022, GL-SUICIDE-2024S
Bone health: baseline vitamin D; lamotrigine is not an enzyme inducer, so no DXA scan is needed unless an enzyme-inducing medicine is addedcompletedGL-AAN-NEWASM-2018S

Goals

GoalTargetStatusOutcomeProvenance
Reach the lamotrigine maintenance dose without rash by the two-month visit2026-05-05completedMaintenance dose of 100 mg twice daily reached after six weeks; no rashS
No seizures for six months after reaching the maintenance dose2026-10-06activeNot met: one generalized tonic-clonic seizure about five months after reaching the maintenance dose, after missed doses and a night without sleep; the six-month count restartsS
Casino and online self-exclusion and a bank gambling block in place by the four-week visit2026-03-03completedSelf-exclusion from casinos in the state and from licensed online sites, and a gambling block on his bank cards, in placeS
No gambling through the eight-month visit2026-10-06activeNot met: no gambling for about seven months, then a lapse while traveling abroad, outside the reach of his self-exclusion; treatment intensifiedS
Written seizure action plan, safety counseling, and a SUDEP discussion completed by the four-week visit2026-03-03completedPlan written and shared with two friends; SUDEP discussed with the neurologistS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-02-03: current ideation absent, intent absent, plan absent. Routine outpatient care. Gambling disorder carries a raised suicide risk, especially after large losses, so safety is reviewed at every visit. He saved the 988 Suicide & Crisis Lifeline and the National Problem Gambling Helpline in his phone and agreed to call either after a large loss or if hopeless thoughts appear. Antiseizure medicine is dispensed as a 30-day supply [S]